Artiva Biotherapeutics, Inc.

Healthcare

NASDAQ:ARTV · NASDAQ Global Market

Market Cap $242.72M Beta 2.40 P/E (TTM) -2.7

$9.82 -3.37%

-$0.34 today

52W Low $1.47High $14.53

Vol 1.75M · Avg 0.48M

EPS (TTM) -$3.53Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+506.17%

Period High

$13.39

Period Low

$1.47

Latest

$9.82

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Sutro Biopharma, Inc.

NASDAQ:STRO

$278.12M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$260.16M

Shattuck Labs, Inc.

NASDAQ:STTK

$232.42M

ALX Oncology Holdings Inc.

NASDAQ:ALXO

$190.41M

InflaRx N.V.

NASDAQ:IFRX

$129.66M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$125.30M

Adverum Biotechnologies, Inc.

ADVM

$96.26M

Precision BioSciences, Inc.

NASDAQ:DTIL

$84.54M

Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

$60.64M

Metagenomi, Inc. Common Stock

MGX

$44.99M

What is the latest ARTV filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does ARTV have?

Intrinsic Alpha currently shows 20 recent filings for ARTV.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.